Search research articles
Contact Us
Filters
Showing results (391-400 of 442) with videos related to
Page
of 45
Sort By:
BMC Infectious Diseases
|
July 16, 2005
Incidence and risk factors for liver enzyme elevation during highly active antiretroviral therapy in HIV-HCV co-infected patients: results from the Italian EPOKA-MASTER Cohort
Carlo Torti, Giuseppe Lapadula, Salvatore Casari, et al.
AIDS (London, England)
|
September 22, 2006
Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV-coinfection
Guenther Schmutz, Mark Nelson, Thomas Lutz, et al.
Plos One
|
July 14, 2023
Hepmarc: A 96 week randomised controlled feasibility trial of add-on maraviroc in people with HIV and non-alcoholic fatty liver disease
Daniel Bradshaw, Iga Abramowicz, Stephen Bremner, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association
|
November 15, 2025
Hazard assessment of insecticidal proteins representing different structural classes using an in vitro experimental platform of human intestinal epithelial monolayers
Cindi S Zimmermann, Sujatha Rajeev Thundivalappil, Brittany Wilson-Mifsud, et al.
Journal of Neurovirology
|
May 20, 2016
Discordant CSF/plasma HIV-1 RNA in patients with unexplained low-level viraemia
Sam Nightingale, Anna Maria Geretti, Apostolos Beloukas, et al.
BMJ Open
|
April 3, 2023
Statins for extension of disability-free survival and primary prevention of cardiovascular events among older people: protocol for a randomised controlled trial in primary care (STAREE trial)
Sophia Zoungas, Andrea Curtis, Simone Spark, et al.
Hypertension (Dallas, Tex. : 1979)
|
June 7, 2017
Efficacy and Safety of Quarter-Dose Blood Pressure-Lowering Agents: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Alexander Bennett, Clara K Chow, Michael Chou, et al.
BMJ (Clinical Research Ed.)
|
November 22, 2012
Effect of intensive structured care on individual blood pressure targets in primary care: multicentre randomised controlled trial
Simon Stewart, Melinda J Carrington, Carla H Swemmer, et al.
Antiviral Therapy
|
June 20, 2017
The association between detected drug resistance mutations and CD4<sup>+</sup> T-cell decline in HIV-positive individuals maintained on a failing treatment regimen
Anna Schultze, Roger Paredes, Caroline Sabin, et al.
The Journal of Antimicrobial Chemotherapy
|
February 26, 2013
Effects of age on antiretroviral plasma drug concentration in HIV-infected subjects undergoing routine therapeutic drug monitoring
Alan Winston, Sophie Jose, Sara Gibbons, et al.
Page
of 45
Search research articles
Search
Showing results (391-400 of 442) with videos related to
Sort By:
Page
of 45
BMC Infectious Diseases
|
July 16, 2005
Incidence and risk factors for liver enzyme elevation during highly active antiretroviral therapy in HIV-HCV co-infected patients: results from the Italian EPOKA-MASTER Cohort
Carlo Torti, Giuseppe Lapadula, Salvatore Casari, et al.
AIDS (London, England)
|
September 22, 2006
Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV-coinfection
Guenther Schmutz, Mark Nelson, Thomas Lutz, et al.
Plos One
|
July 14, 2023
Hepmarc: A 96 week randomised controlled feasibility trial of add-on maraviroc in people with HIV and non-alcoholic fatty liver disease
Daniel Bradshaw, Iga Abramowicz, Stephen Bremner, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association
|
November 15, 2025
Hazard assessment of insecticidal proteins representing different structural classes using an in vitro experimental platform of human intestinal epithelial monolayers
Cindi S Zimmermann, Sujatha Rajeev Thundivalappil, Brittany Wilson-Mifsud, et al.
Journal of Neurovirology
|
May 20, 2016
Discordant CSF/plasma HIV-1 RNA in patients with unexplained low-level viraemia
Sam Nightingale, Anna Maria Geretti, Apostolos Beloukas, et al.
BMJ Open
|
April 3, 2023
Statins for extension of disability-free survival and primary prevention of cardiovascular events among older people: protocol for a randomised controlled trial in primary care (STAREE trial)
Sophia Zoungas, Andrea Curtis, Simone Spark, et al.
Hypertension (Dallas, Tex. : 1979)
|
June 7, 2017
Efficacy and Safety of Quarter-Dose Blood Pressure-Lowering Agents: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Alexander Bennett, Clara K Chow, Michael Chou, et al.
BMJ (Clinical Research Ed.)
|
November 22, 2012
Effect of intensive structured care on individual blood pressure targets in primary care: multicentre randomised controlled trial
Simon Stewart, Melinda J Carrington, Carla H Swemmer, et al.
Antiviral Therapy
|
June 20, 2017
The association between detected drug resistance mutations and CD4<sup>+</sup> T-cell decline in HIV-positive individuals maintained on a failing treatment regimen
Anna Schultze, Roger Paredes, Caroline Sabin, et al.
The Journal of Antimicrobial Chemotherapy
|
February 26, 2013
Effects of age on antiretroviral plasma drug concentration in HIV-infected subjects undergoing routine therapeutic drug monitoring
Alan Winston, Sophie Jose, Sara Gibbons, et al.
Page
of 45